Table 3 Prognostic factors for overall survival in patients who received chemotherapy with gemcitabine and albumin-bound paclitaxel.

From: Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma

 

n

Hazard ratio (95% CI)

P value*

Age

 74≤ years old

55

reference

 

 66–73 years old

89

1.159 (0.807–1.664)

0.42

 ≤65 years old

80

1.357 (0.891–2.066)

0.15

Sex

 Female

95

reference

 

 Male

129

1.395 (0.929–2.095)

0.11

UICC stage

 I-II

15

reference

 

 III

40

1.074 (0.464–2.488)

0.87

 IV, Recurrent

169

3.061 (1.469–6.377)

0.003

CEA

 <5.3 ng/mL

112

reference

 

 ≥5.3 ng/mL

112

1.125 (0.785–1.613)

0.52

CA19-9

 <1155 U/mL

112

reference

 

 ≥1155 U/mL

112

1.356 (0.956–1.922)

0.087

LG2m

 <34.9 pg/mL

112

reference

 

 ≥34.9 pg/mL

112

1.781 (1.274–2.490)

<0.001

  1. *Cox’s proportional hazards regression model.